Schedule 13D ownership disclosure
Flex Pharma, Inc.
Security class unavailable · CUSIP: 33938A105
Event date: 2018-10-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,941,118
- Percent of class
- 21.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-18-064175
- Form type
- SC 13D
- Filer
- Salarius Pharmaceuticals, Inc.
- CIK
- CIK 1615219
- Filed
- Oct 26, 2018
- Reporting period
- Oct 16, 2018
- Description
- Schedule 13D beneficial ownership